Luminex Corporation to Present at Cowen and Company's 31st Annual Health Care Conference
AUSTIN, Texas, March 2, 2011 - Luminex Corporation (Nasdaq: LMNX) today announced that senior management will present at the 31st Annual Health Care Conference to be held March 7 -9, 2011, in Boston, MA.
The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 1:20 p.m. Eastern time on Tuesday, March 8, 2011. The presentation will be webcast live and may be accessed at Luminex Corporation's website at www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.
ABOUT LUMINEX CORPORATION
Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP technology can be obtained at www.luminexcorp.com.
SOURCE Luminex Corporation
CONTACT: Harriss T. Currie, Vice President, Finance and Chief Financial Officer, or Matthew Scalo, Sr. Director of Investor Relations, mscalo@luminexcorp.com, both of Luminex Corporation, +1-512-219-8020
Web Site: www.luminexcorp.com
